March 28 (SeeNews) - Romanian drug maker Biofarm [BSE:BIO] said on Monday that it targets a 15% rise in earnings before interest, taxes, depreciation and amortisation (EBITDA) to 82 million lei ($18.2 million/ 16.6 million euro) this year and plans to expand on new markets.